<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01315340</url>
  </required_header>
  <id_info>
    <org_study_id>8068</org_study_id>
    <nct_id>NCT01315340</nct_id>
  </id_info>
  <brief_title>Ocular Rigidity and Outflow Facility in Glaucomatous and Normal Eyes</brief_title>
  <official_title>Measurement of Ocular Rigidity, Outflow Facility and Ocular Blood Flow in Glaucomatous and Normal Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Larissa University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Crete</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Larissa University Hospital</source>
  <brief_summary>
    <textblock>
      Ocular rigidity characterizes the relationship between pressure and volume changes in the
      human eye and is expressed as a macroscopic coefficient. Outflow facility is a measure of the
      resistance of the conventional outflow pathway and represents a parameter that is of interest
      in glaucoma.

      Difficulties in the measurement of ocular rigidity in the living human eye have limited our
      knowledge on this parameter. However, ocular biomechanics have been implicated in the
      pathogenesis of this disease. The aim of this study is to characterize the pressure volume
      relation and quantify ocular rigidity and outflow facility in glaucomatous and normal eyes.
      For this purpose, the investigators have recently developed a manometric method for the
      measurement of ocular rigidity and outflow facility.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular rigidity coefficient</measure>
    <time_frame>2 minutes measurement of ocular rigidity</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Outflow facility coefficient</measure>
    <time_frame>3-4 minutes measurement of outflow facility</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular pulse amplitude</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulsatile ocular blood flow</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ocular rigidity, outflow facility and intraocular pressure measurement</intervention_name>
    <description>The measurement procedure includes cannulation of the anterior chamber of the eye, under sterile conditions. Infusion of the eye with microvolumes of a saline solution is performed, followed by manometric measurement of intraocular pressure, in order to quantify ocular rigidity. Outflow facility is estimated from recordings of intraocular pressure after the infusion is stopped.</description>
    <arm_group_label>Glaucoma Patients</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with primary open or pseudoexfoliation glaucoma that are undergoing cataract
             surgery

          -  Patients undergoing cataract surgery without evidence of other ocular disease.

        Exclusion Criteria:

          -  Evidence of any ocular disease, other than specified in the inclusion criteria

          -  Previous ophthalmic surgery or trauma

          -  Significant visual field defect (MD&lt;-12dB) or an increased cup to disc ratio (&gt;0.9).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioannis Pallikaris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Crete</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ioannis Pallikaris, MD</last_name>
    <phone>2810392351</phone>
    <phone_ext>+30</phone_ext>
    <email>ioanpall@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ophthalmology Department, University Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <zip>41110</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Dastiridou, MD</last_name>
      <email>anna.dastiridou@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anna Dastiridou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Dastiridou AI, Ginis HS, De Brouwere D, Tsilimbaris MK, Pallikaris IG. Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure. Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5718-22. doi: 10.1167/iovs.09-3760. Epub 2009 Jul 15.</citation>
    <PMID>19608534</PMID>
  </reference>
  <reference>
    <citation>Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Christodoulakis E, Tsilimbaris MK. Ocular rigidity in patients with age-related macular degeneration. Am J Ophthalmol. 2006 Apr;141(4):611-5.</citation>
    <PMID>16564793</PMID>
  </reference>
  <reference>
    <citation>Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Tsilimbaris MK. Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):409-14.</citation>
    <PMID>15671262</PMID>
  </reference>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2011</study_first_posted>
  <last_update_submitted>March 16, 2011</last_update_submitted>
  <last_update_submitted_qc>March 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ioannis Pallikaris</name_title>
    <organization>University of Crete</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

